JPMorgan Chase & Co

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-12
Total Holdings
26,591
Total Value
1174196921659
Accession Number
0000019617-25-000443
Form Type
13F-HR
Manager Name
JPMorgan Chase & Co
Data Enrichment
81% identified
21,604 identified4,987 unidentified

Holdings

26,591 positions
Manager:
Search and click to pin securities to the top
Page 323 of 365
46138J775
Shares:
51(-76.3%)
Value:
$4.2M(-76.0%)
Shares:
5000
Value:
$4.1M
698813902
Shares:
100
Value:
$4.1M
LIGHTBRIDGE Corp
Shares:
550(+0.0%)
Value:
$4.1M(+57.7%)
731068902
Shares:
100
Value:
$4.1M
PLBY Group, Inc.
Shares:
3719(+0.0%)
Value:
$4.1M(-24.6%)
Protalix BioTherapeutics, Inc.
Shares:
1595(+0.0%)
Value:
$4.1M(+36.1%)
00888H703
Shares:
116(+0.0%)
Value:
$4.1M(-2.6%)
BlackRock Capital Allocation Term Trust
Shares:
277(+2977.8%)
Value:
$4.0M(+2833.1%)
OptiNose, Inc.
Shares:
431(-4.0%)
Value:
$4.0M(+31.8%)
82655M206
Shares:
914(+6428.6%)
Value:
$3.9M(+9680.0%)
713715100
Shares:
3500
Value:
$3.9M
92189F528
Shares:
224(-20.8%)
Value:
$3.8M(-20.6%)
12811T688
Shares:
154
Value:
$3.8M
Eaton Vance Ltd Duration Income Fund
Shares:
378(-0.3%)
Value:
$3.8M(+1.9%)
33939L860
Shares:
55(-93.8%)
Value:
$3.8M(-94.0%)
35473P108
Shares:
115(-4.2%)
Value:
$3.7M(+4.1%)
45782C623
Shares:
137(+0.0%)
Value:
$3.7M(+2.7%)
878742904
Shares:
100(-100.0%)
Value:
$3.6M(-100.0%)
Monopar Therapeutics
Shares:
100(-95.1%)
Value:
$3.6M(-91.9%)